<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38652838</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2164-554X</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Dec</Month><Day>31</Day></PubDate></JournalIssue><Title>Human vaccines &amp; immunotherapeutics</Title><ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation></Journal><ArticleTitle>The need for development of other enterovirus vaccines in addition to EV-A71 vaccine.</ArticleTitle><Pagination><StartPage>2340854</StartPage><MedlinePgn>2340854</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2340854</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2024.2340854</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Daoyan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Infectious Diseases Department, Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital), Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jian</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-7406-841X</Identifier><AffiliationInfo><Affiliation>Infectious Diseases Department, Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital), Jinan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Vaccin Immunother</MedlineTA><NlmUniqueID>101572652</NlmUniqueID><ISSNLinking>2164-5515</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>doi: 10.1080/21645515.2023.2209472</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="Y">Viral Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000087506" MajorTopicYN="N">Vaccine Development</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>24</Day><Hour>1</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>23</Day><Hour>18</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>23</Day><Hour>15</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38652838</ArticleId><ArticleId IdType="pmc">PMC11141467</ArticleId><ArticleId IdType="doi">10.1080/21645515.2024.2340854</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang Y, Feng Z, Yang Y, Self S, Gao Y, Longini IM, Wakefield J, Zhang J, Wang L, Chen X, et al. Hand, foot, and mouth disease in China: patterns of spread and transmissibility. Epidemiology. 2011;22(6):781–2. doi: 10.1097/EDE.0b013e318231d67a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e318231d67a</ArticleId><ArticleId IdType="pmc">PMC3246273</ArticleId><ArticleId IdType="pubmed">21968769</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Sun J, Chang Z, Zhang W, Wang Z, Feng Z.. Characterization of hand, foot, and mouth disease in China between 2008 and 2009. Biomed Environ Sci. 2011;24(3):214–21. doi: 10.3967/0895-3988.2011.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.3967/0895-3988.2011.03.002</ArticleId><ArticleId IdType="pubmed">21784305</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee TC, Guo HR, Su HJ, Yang YC, Chang HL, Chen KT. Diseases caused by enterovirus 71 infection. Pediatr Infect Dis J. 2009;28(10):904–10. doi: 10.1097/INF.0b013e3181a41d63.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0b013e3181a41d63</ArticleId><ArticleId IdType="pubmed">20118685</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Liu L, Mo Z, Wang X, Xia J, Liang Z, Zhang Y, Li Y, Mao Q, Wang J, et al. An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med. 2014;370(9):829–37. doi: 10.1056/NEJMoa1303224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1303224</ArticleId><ArticleId IdType="pubmed">24571755</ArticleId></ArticleIdList></Reference><Reference><Citation>Saguil A, Kane SF, Lauters R, Mercado MG. Hand-foot-and mouth disease: rapid evidence review. Am Fam Physician. 2019;100:408–14.</Citation><ArticleIdList><ArticleId IdType="pubmed">31573162</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia J, Kong F, Xin X, Liang J, Xin H, Dong L, Jiang F. Epidemiological characteristics of hand, foot, and mouth disease outbreaks in Qingdao, 2009–2018. Iran J Public Health. 2021;50(5):999–1008. doi: 10.18502/ijph.v50i5.6117.</Citation><ArticleIdList><ArticleId IdType="doi">10.18502/ijph.v50i5.6117</ArticleId><ArticleId IdType="pmc">PMC8223573</ArticleId><ArticleId IdType="pubmed">34183958</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Chang Z, Wu P, Liao Q, Liu F, Zheng Y, Luo L, Zhou Y, Chen Q, Yu S, et al. Emerging enteroviruses causing hand, foot and mouth disease, China, 2010–2016. Emerg Infect Dis. 2018;24(10):1902–6. doi: 10.3201/eid2410.171953.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2410.171953</ArticleId><ArticleId IdType="pmc">PMC6154135</ArticleId><ArticleId IdType="pubmed">30226172</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian L, Wang Y, Yao X, Mao Q, Xu M, Liang Z. Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide. Expert Rev Anti Infect Ther. 2015;13(9):1061–71. doi: 10.1586/14787210.2015.1058156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14787210.2015.1058156</ArticleId><ArticleId IdType="pubmed">26112307</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu QB, Zhang XA, Wo Y, Xu HM, Li XJ, Wang XJ, Ding SJ, Chen XD, He C, Liu LJ, et al. Circulation of coxsackievirus A10 and A6 in hand-foot-mouth disease in China, 2009–2011. PLoS One. 2012;7(12):e52073. doi: 10.1371/journal.pone.0052073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052073</ArticleId><ArticleId IdType="pmc">PMC3525556</ArticleId><ArticleId IdType="pubmed">23272213</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y, Jiang Q, Huo X, Yu L, Yang J, Zhao H, Li D, Xu X, Jiang G, Zhang C, et al. Preclinical safety evaluation of a bivalent inactivated EV71-CA16 vaccine in mice immunized intradermally. Hum Vaccin Immunother. 2023;19(1):2209472. doi: 10.1080/21645515.2023.2209472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2023.2209472</ArticleId><ArticleId IdType="pmc">PMC10208166</ArticleId><ArticleId IdType="pubmed">37217189</ArticleId></ArticleIdList></Reference><Reference><Citation>CDE . 2008. (China). The general principles for the technical review of pre-clinical safety evaluation of biological products for prevention.</Citation></Reference><Reference><Citation>Verdier F, Barrow PC, Burge J. Reproductive toxicity testing of vaccines. Toxicology. 2003;185(3):213–9. doi: 10.1016/S0300-483X(02)00611-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0300-483X(02)00611-X</ArticleId><ArticleId IdType="pubmed">12581696</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebron JA, Wolf JJ, Kaplanski CV, Ledwith BJ. Ensuring the quality, potency and safety of vaccines during preclinical development. Expert Rev Vaccines. 2005;4(6):855–66. doi: 10.1586/14760584.4.6.855.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.4.6.855</ArticleId><ArticleId IdType="pubmed">16372881</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldrick P. Dose site reactions and related findings after vaccine administration in safety studies. J Appl Toxicol. 2016;36(8):980–90. doi: 10.1002/jat.3314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jat.3314</ArticleId><ArticleId IdType="pubmed">26968331</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>